Drug Use Investigation for Cell-culture Derived Influenza A (H1N1) Emulsion HA Vaccine

556 participants · First posted Apr 5, 2010

Post-License Safety Evaluation of Influenza Virus Vaccine

400,000 participants · First posted May 12, 2014

Oral Triple Combination Antiviral Drug Therapy for Treatment of Influenza A in Immunocompromised Subjects

2 participants · First posted Sep 17, 2009

Influenza SiRNA Drug (Walvax Biotechnology)

drug candidate (Influenza)

drug candidate

Research Institute of Influenza

Russia

Hunan Nucien Pharmaceutical Co., Ltd.

Redpharm Drug

United States

China Approves First-in-Class Influenza Drug Onradivir Targeting Novel PB2 Protein

Roche Partners with UN-Backed Group to Expand Global Access to Influenza Drug Xofluza

hVIVO's hLAB Secures £2.7 Million Contract for Influenza Drug Trial